Navigation Links
FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI's Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
Date:4/28/2009

OR AKIVA, Israel, April 28 /PRNewswire-FirstCall/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged in research, development, manufacturing and marketing of heterologous tissue covered stents, announced that the US Food and Drug Administration (FDA) has granted HUD (Humanitarian Use Device) designation to Over and Under(R) and Aneugraft(R) Pericardium Covered Stents for treatment of perforations and dissections of native coronary arteries and Saphenous Vein Grafts.

This is the first step towards obtaining marketing approval.

Over and Under(R) and AneuGraft(R) are stents 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. Stents are commercially available in Europe, Israel and Latin America for treatment of Saphenous Vein Graft stenosis, aneurysms and for emergency situations such as perforations.

About Pericardium Covered Stents

Pericardium Covered Stents are unique stents covered with heterologous tissue designed to set a barrier between the blood vessel wall and its lumen. Pericardium Covered Stents are indicated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations.

About ITGI Medical

ITGI medical is engaged in research and development, manufacturing and marketing of heterologous tissue covered stents. ITGI's stents are already commercially available in Europe, Israel and Latin America. The world stent market has a value estimation of 6.4 Billion USD, of which 37% are generated in the USA.

    Danna Moran
    VP Marketing
    ITGI Medical Ltd.
    P: +972-72-2200335
    dannam@itgimedical.com



'/>"/>
SOURCE ITGI Medical LTD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
2. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
3. VIASPACE Granted US Patent
4. Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
5. Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe
6. Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
7. GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform
8. BioLife Solutions Granted European Biopreservation Patent
9. ScinoPharm Granted US Patent for Novel Crystal Forms
10. Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
11. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Bedford, NH (PRWEB) January 22, 2015 ... offers a table top laboratory homogenizer, the PandaPLUS 2000, ... nanoparticles, nanodispersions, nanoemulsions , and cell disruption . ... processing dairy products, fruit juices, liquid food, food additives ...
(Date:1/22/2015)... January 22, 2015 Protocol Networks brings ... growing team of brand-neutral, independent consultants, Protocol Networks has ... explained that over the years, his company has attracted ... Town of Plainfield, as well as others. With the ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was ... Pre-Conference seminar on probiotics in San Diego, CA. , ... conference for health care professionals. This year’s pre-conference seminar was ... in health. Dr. Leyer spoke about the emerging topics and ...
(Date:1/22/2015)... Jersey , 22 de enero de 2015  El Dr. ... hoy su llamada a nominaciones para 2015. Este prestigioso ... hecho, o tiene el potencial para hacer, contribuciones destacadas ... se aceptarán hasta el 15 de marzo de 2015 ...
Breaking Biology Technology:GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... 12 Epeius Biotechnologies Corporation today announced more stunning ... world,s first and, so far only, tumor-targeted genetic medicine ... therapy in late-stage cases of chemotherapy-resistant cancer, Rexin-G has ... much-touted biologics have failed to do: that is, to ...
... ImaginAb, Inc. and BZL Biologics, LLC have concluded ... field of diagnostic imaging for PET and SPECT. "ImaginAb ... BZL as we believe that huJ591 will form the ... and management of prostate cancer. BZL,s technology has extensive ...
... Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: ... treatment phase of its open-label Phase 2a clinical trial ... with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver ... U.S. population. At the completion of the initial six-month ...
Cached Biology Technology:Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine 2Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine 3ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA) 2Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 2Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 3Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 4Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 5Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 6
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & ... http://photos.prnewswire.com/prnh/20130307/600769 ... introduced the fingerprint reading feature with the iPhone 5S. ...
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the leading personal ... pinpoints fine-scale differences in genetic ancestry of individuals from across ... immigrants first arrived more than four hundred years ago, ... meeting place for peoples from different continents. This study illuminates ...
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home Button ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the iPhone 5S, Samsung introduces for the first time ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... copper industry is working together to answer one very ... bronze) help curb the spread of bacteria that cause ... indicate that they can. Scientists from around the world ... and Public Health, on copper,s role in fighting the ...
... 2009 Responding to the growing popularity of a ... it is developing a new standard to be included ... food and beverage manufacturers assure the product,s quality for ... beverage industry as well as all other interested parties ...
... filament lamin A/C (LMNA) gene are associated with Emery-Dreifuss muscular ... al. show that one mechanism involves the disruption of neuromuscular ... January 5, 2009 ( www.jcb.org ) and in the January ... Biology . Muscle fiber cells contain hundreds of ...
Cached Biology News:International copper industry defines role in the fight against hospital infections 2New standard for popular stevia-based sweetener to assure product's quality 2
...
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature....
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
... DNase I Amplification ... double-stranded DNA to oligodeoxyribonucleotides. ... >10000 units/mg. DNAse I ... purified and tested for ...
Biology Products: